Ketamine Infusion for Adolescent Depression and Anxiety
Completed · Phase 4 · Has a placebo group
Conditions studied: Major Depressive Disorder, Anxiety Disorder
In brief
The purpose of this study is to determine the tolerability and short-term efficacy of a single ketamine infusion for the treatment of adolescents with 1) medication-refractory major depressive disorder (MDD) and/or 2) medication-refractory anxiety disorders (social anxiety disorder, panic disorder, generalized anxiety disorder and/or separation anxiety disorder).
Key facts
- Study ID
- NCT02579928
- Run by
- Yale University
- People needed
- 17
- Starts
- 2015-10-01
- Expected to finish
- 2019-09-01
- Last updated by the study team
- 2020-07-14
Who can join
Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hospital Research Unit at the Yale New Haven Hospital — New Haven, Connecticut, United States
- Yale Child Study Center — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.